Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Neurology
|
August 26, 1998
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group
G D Borasio, W Robberecht, P N Leigh, et al.
Annals of Neurology
|
July 1, 1997
Copper and zinc levels in familial amyotrophic lateral sclerosis patients with CuZnSOD gene mutations
A Radunović, H T Delves, W Robberecht, et al.
Human Genetics
|
January 1, 1996
Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP)
V Timmerman, A Löfgren, E Le Guern, et al.
Neurology
|
February 9, 2005
Myosin storage myopathy: slow skeletal myosin (MYH7) mutation in two isolated cases
N G Laing, C Ceuterick-de Groote, D E Dye, et al.
Neurology
|
May 13, 2011
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2
P Van Damme, J H Veldink, M van Blitterswijk, et al.
Experimental Neurology
|
April 2, 2002
Protective effect of parvalbumin on excitotoxic motor neuron death
L Van Den Bosch, B Schwaller, V Vleminckx, et al.
Neurology
|
September 30, 2010
Mutations in SACS cause atypical and late-onset forms of ARSACS
J Baets, T Deconinck, K Smets, et al.
Human Molecular Genetics
|
November 18, 1998
Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor
A Al-Chalabi, P M Andersen, B Chioza, et al.
Neurology
|
January 11, 2008
Progranulin genetic variability contributes to amyotrophic lateral sclerosis
K Sleegers, N Brouwers, S Maurer-Stroh, et al.
Neurology
|
May 26, 2010
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse
I Taes, A Goris, R Lemmens, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Neurology
|
August 26, 1998
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group
G D Borasio, W Robberecht, P N Leigh, et al.
Annals of Neurology
|
July 1, 1997
Copper and zinc levels in familial amyotrophic lateral sclerosis patients with CuZnSOD gene mutations
A Radunović, H T Delves, W Robberecht, et al.
Human Genetics
|
January 1, 1996
Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP)
V Timmerman, A Löfgren, E Le Guern, et al.
Neurology
|
February 9, 2005
Myosin storage myopathy: slow skeletal myosin (MYH7) mutation in two isolated cases
N G Laing, C Ceuterick-de Groote, D E Dye, et al.
Neurology
|
May 13, 2011
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2
P Van Damme, J H Veldink, M van Blitterswijk, et al.
Experimental Neurology
|
April 2, 2002
Protective effect of parvalbumin on excitotoxic motor neuron death
L Van Den Bosch, B Schwaller, V Vleminckx, et al.
Neurology
|
September 30, 2010
Mutations in SACS cause atypical and late-onset forms of ARSACS
J Baets, T Deconinck, K Smets, et al.
Human Molecular Genetics
|
November 18, 1998
Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor
A Al-Chalabi, P M Andersen, B Chioza, et al.
Neurology
|
January 11, 2008
Progranulin genetic variability contributes to amyotrophic lateral sclerosis
K Sleegers, N Brouwers, S Maurer-Stroh, et al.
Neurology
|
May 26, 2010
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse
I Taes, A Goris, R Lemmens, et al.
Page
of 9